Smartwatch exercise plan aims to rebuild fitness in young cancer survivors
NCT ID NCT07729059
First seen Jul 27, 2026 · Last updated Jul 28, 2026 · Updated 1 time
Summary
This trial tests whether a personalized, smartwatch-supported home exercise program can increase physical activity and improve heart health, mobility, and quality of life in adolescents and young adults who have survived bone or soft tissue sarcoma. Participants wear a fitness tracker and are randomly assigned to either receive an individualized exercise plan with online coaching or continue usual care. The study measures changes in daily activity, fitness, and well-being over an 8-week period.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- an individualized, partially supervised home-based exercise program supported by a smartwatch
- What this could lead to
- If it works, this could point toward a standard exercise support program to improve long-term health and quality of life for young sarcoma survivors.
- What could go wrong
- This is a small, early-stage trial with only 46 participants, so results may not apply to all survivors. The exercise program requires motivation and access to a smartphone, which may limit participation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BONE SARCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Patient's own immune cells fight advanced sarcoma?
- Can tailored exercise help young sarcoma survivors recover strength?
- Blood test aims to spot hidden cancer cells in 9 tumor types
- New drug combo aims to fight rare sarcoma
- Experimental vaccine fights sarcoma with Patient's own immune cells
- Experimental t cell therapy targets sarcoma in small early trial